ERBB2 and cancer: In comparison with FISH assay, the conventional standard for detecting single biomarker status such as HER2 amplification, MIP microarray can provide accurate and quantitative assessment of copy number gain/amplification and loss for nearly 900 cancer related genes as well as copy neutral loss of heterozygosity (LOH) of genes within chromosomal segments [19, 21].